Table 1 Baseline characteristics for included and not included patients
From: Prevalence of airflow obstruction in patients with stable systolic heart failure
Included | P-value | Not included | P-value | ||
|---|---|---|---|---|---|
Baseline + FU performed (n = 338) | Only Baseline performed (n = 252) | FU/no FU | (n = 101) | Included/not included | |
Age years (SD) | 69 (11) | 68 (12) | 0.61 | 71 (12) | 0.59 |
Female gender n(%) | 89 (27%) | 67 (26%) | 0.95 | 36 (36%) | 0.04 |
NYHA III-IV n(%) | 74 (25%) | 61 (27%) | 0.50 | 20 (20%) | 0.03 |
Known COPD n(%) | 44 (13%) | 27 (11%) | 0.27 | 12 (12%) | 0.52 |
Previous or present smoking n(%) | 238 (72%) | 189 (78%) | 0.14 | 73 (77%) | 0.70 |
Body mass index kg/m2 (SD) | 27 (5) | 27 (5) | 0.50 | 27 (6) | 0.46 |
Systolic blood pressure mmHg (SD) | 130 (22) | 130 (25) | 0.59 | 119 (22) | <0.01 |
Diastolic blood pressure mmHg (SD) | 77 (13) | 76 (11) | 0.82 | 69 (15) | <0.01 |
Heart rate/minute (SD) | 74 (15) | 75 (14) | 0.56 | 74 (13) | 0.98 |
Ejection fraction % (SD) | 31 (9) | 31 (9) | 0.46 | 31 (9) | 0.52 |
eGFR’ ml/min (SD) | 85 (124) | 76 (102) | 0.63 | 82 (118) | 0.79 |
Sodium mmol/l (SD) | 138 (4) | 137 (4) | 0.02 | 139 (1.4) | 0.54 |
Potassium mmol/l (SD) | 4.2 (0.5) | 4.2 (0.5) | 0.69 | 4.1 (0.4) | 0.61 |
Treated with ACEI/ARB n(%) | 308 (92%) | 233 (92%) | 0.89 | 87 (86%) | 0.21 |
Treated with β-blocker n(%) | 259 (77%) | 197 (80%) | 0.48 | 67 (66%) | 0.31 |
Treated with loop-diuretics n(%) | 200 (60%) | 150 (61%) | 0.88 | 53 (52%) | 0.38 |
Treated with thiazides n(%) | 29 (9%) | 18 (7%) | 0.26 | 10 (10%) | 0.57 |
Treated with spironolactone n(%) | 59 (18%) | 53 (21%) | 0.29 | 26 (26%) | 0.06 |